ChIPAb+ Phospho-Histone H3 (Thr3) - ChIP Validated Antibody and Primer Set, rabbit monoclonal

All ChIPAb+ antibodies are individually validated for chromatin precipitation, every lot, every time. Each ChIPAb+ antibody set includes control primers (tested every lot by qPCR) to biologically validate your IP results in a locus-specific context. The qPCR protocol and primer sequences are provided, allowing researchers to validate ChIP protocols when using our antibody in their chromatin context. Each set also includes a negative control antibody to ensure specificity of the ChIP reaction.
The ChIPAb+ Phospho-Histone H3 (Thr3) set includes the Phospho-Histone H3 (Thr3) antibody, a negative control supernatant, and control primers which amplify a 166 bp region of human GAPDH promoter. The Phospho-Histone H3 (Thr3) and negative controls are supplied in a scalable "per ChIP" reaction size and can be used to functionally validate the precipitation of Phospho-Histone H3 (Thr3)-associated chromatin.

Histone H3 is one of the five main histone proteins involved in the structure of chromatin in eukaryotic cells. Featuring a main globular domain and a long N-terminal tail, H3 is involved with the structure of the nucleosomes of the ′beads on a string′ structure.

The N-terminal tail of histone H3 protrudes from the globular nucleosome core and can undergo several different types of epigenetic modifications that influence cellular processes. These modifications include the covalent attachment of methyl or acetyl groups to lysine and arginine amino acids and the phosphorylation of serine or threonine.

Histone H3 phosphorylated at Threonine 3; cross-reactivity with phospho-histone H3 Thr22 detected in some applications

Epitope: Phosphorylated Thr3

Peptide containing the sequence [RT_trimKQ] in which lysine 4 is trimethylated on human histone H3

Chromatin Immunoprecipitation:
Representative lot data.
Sonicated chromatin prepared from untreated or colcemid-treated HeLa cells (1 X 10E6 cell equivalents per IP) were subjected to chromatin immunoprecipitation using 2 µL of either Negative Control Supernatant, or 2 µL ofAnti-Phospho-Histone H3 (Thr3) and the Magna ChIP^® A Kit (Cat. # 17-610). Successful immunoprecipitation of Phospho-Histone H3 (Thr3) associated DNA fragments was verified by qPCR using ChIP Primers, human GAPDH promoter Region for untreated and treated chromatin samples. Data is presented as percent input of each IP sample relative to input chromatin for each amplicon and ChIP sample as indicated.
Please refer to the EZ-Magna ChIP A (Cat. # 17-408) or EZ-ChIP (Cat. # 17-371) protocol for experimental details.
Western Blot Analysis:
Representative lot data.
Recombinant histone H3 (Lane 1) and acid extracts from untreated (Lane 2) or colcemid treated (Lane 3) HeLa cells were resolved by
electrophoresis, transferred to nitrocellulose and probed with anti-Phospho-Histone H3 (Thr3), clone JY325 (10 ng/mL). Proteins were visualized using a goat anti-rabbit secondary antibody conjugated to HRP and a chemiluminescence detection system.
Arrow indicates Phospho- Histone H3 (~17 kDa).
Dot Blot:
Representative lot data.
A dilution series of Histone H3 peptides containing the following modifications was made:
Column 1: Phospho-threonine 3
Column 2: unmodified, containing Thr3
Column 3: Phospho-threonine 6
Column 4: Phospho-threonine 11
Column 5: Phospho-threonine 22
Column 6: Phospho-serine 10
Column 7: Phospho-threonine 80
Column 8: Phospho-serine 28
2 μL of each dilution was spotted onto PVDF membranes and probed with Anti-Phospho- Histone H3 (Thr3), clone JY325 (20 ng/mL)
Peptides were visualized using a Goat Anti-Rabbit secondary antibody conjugated to HRP and a chemiluminescence detection system..

Research Category
Epigenetics & Nuclear Function

Research Sub Category
Histones

This ChIPAb+ Phospho-Histone H3 (Thr3) -ChIP Validated Antibody & Primer Set conveniently includes the antibody & the specific control PCR primers.

25 assays per set. Recommended use: ~2 μL of antibody per chromatin immunoprecipitation (dependent upon biological context).

Chromatin Immunoprecipitation:
Representative lot data.
Sonicated chromatin prepared from colcemid-treated HeLa cells (1 X 10E6 cell equivalents per IP) were subjected to chromatin immunoprecipitation using 2 µL of either Negative Control Supernatant, or 2 µL Anti-Phospho-Histone H3 (Thr3) and the Magna ChIP^® A Kit (Cat. # 17-610). Successful immunoprecipitation of Phospho-Histone H3 (Thr3) associated DNA fragments was verified by qPCR using ChIP Primers, human GAPDH promoter Region.
Please refer to the EZ-Magna ChIP A (Cat. # 17-408) or EZ-ChIP (Cat. # 17-371) protocol for experimental details.

17 kDa

Anti-Phospho-Histone H3 (Thr3) (rabbit monoclonal). One vial containing 50 µL of cultured supernantant in 0.05% sodium azide. Store at -20°C.
Negative Control Supernatant. One vial containing 100 µL of cultured supernatant in 0.05% sodium azide. Store at -20°C.
Control Primers, human GAPDH promoter. One vial containing 75 μL of 5 μM of each primer specific for human GAPDH. Store at -20°C.
FOR: TAC TAG CGG TTT TAC GGG CG
REV: TCG AAC AGG AGG AGC AGA GAG CGA

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon first thaw, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Control
Includes negative control supernatant and primers specific for human GAPDH promoter.

MAGNA CHIP is a registered trademark of Merck KGaA, Darmstadt, Germany

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.